22 May 2013
Keywords: another, negative, gsk, avandia, takeda/lilly, actos, even
Article | 06 August 2007
Even as they await the deliberations of the US Food and Drug Administration's Metabolic Drugs and Drug Safety Advisory Committee ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 August 2007
26 July 2007
21 May 2013
© 2013 thepharmaletter.com